TheraCell Expands License Agreement with Australian Biotechnologies

TheraCell Demineralized Bone Fiber

TheraCell expanded its licensing agreement with Australian Biotechnologies to include exclusive rights to produce and market a portfolio of demineralized fiber grafts for the Australian and New Zealand markets.

The existing license, addressing TheraCell's base demineralized fiber technology, now includes a full portfolio of novel...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us